A Phase IV Study in Drug-Naive Patients With T2DM in China

Clinical trial NCT03344341 · TERMINATED

Trial details

NCT number: NCT03344341
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2017-12-15
Primary completion: 2019-05-24
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.